Literature DB >> 8547406

Interferons: laboratory to clinic investigations.

L C Platanias1.   

Abstract

Interferons are pleiotropic cytokines that exhibit multiple biological effects on cells and tissues, including antiproliferative, antiviral, and immunomodulatory activities. Despite the well-documented activity of interferons in the treatment of certain malignancies, the precise mechanisms by which these cytokines inhibit malignant cell growth remain unknown. Recently, several laboratory studies have provided important clues on the cellular events elicited during the binding of interferons to their receptors on malignant cells. The continuation and expansion of such studies should help us understand the mechanisms by which interferons elicit their antitumor effects and provide a basis for the development of new strategies in their clinical use.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547406

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  7 in total

1.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.

Authors:  Lorraine Tracey; Raquel Villuendas; Pablo Ortiz; Ana Dopazo; Inmaculada Spiteri; Luis Lombardia; Jose L Rodríguez-Peralto; Jesús Fernández-Herrera; Almudena Hernández; Javier Fraga; Orlando Dominguez; Javier Herrero; Miguel A Alonso; Joaquin Dopazo; Miguel A Piris
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway.

Authors:  Zhimei Du; Yuhong Shen; Wentian Yang; Ingrid Mecklenbrauker; Benjamin G Neel; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-06       Impact factor: 11.205

Review 3.  An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action.

Authors:  W J Gradishar
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

4.  Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts.

Authors:  Qunfang Li; Lin Tang; Paul Christopher Roberts; Janice M Kraniak; Aviva Levine Fridman; Olga I Kulaeva; Omid S Tehrani; Michael A Tainsky
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

5.  Cellular Response to Individual Components of the Platelet Concentrate.

Authors:  Vera Sovkova; Karolina Vocetkova; Věra Hedvičáková; Veronika Hefka Blahnová; Matěj Buzgo; Evzen Amler; Eva Filová
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

6.  Dipyrithione inhibits IFN-gamma-induced JAK/STAT1 signaling pathway activation and IP-10/CXCL10 expression in RAW264.7 cells.

Authors:  Cui Han; Jin Fu; Ziwen Liu; Huang Huang; Lan Luo; Zhimin Yin
Journal:  Inflamm Res       Date:  2010-04-07       Impact factor: 4.575

Review 7.  The role of type 1 interferon in systemic sclerosis.

Authors:  Minghua Wu; Shervin Assassi
Journal:  Front Immunol       Date:  2013-09-06       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.